Efficacy and Safety of the Combination Streptozotocin, 5-FU in Endocrine Pancreatic Tumors: A Retrospective Study

被引：0
|
作者：
Antonodimitrakis, P. [1 ]
Skogseid, B. [1 ]
Hurtig, M. [1 ]
Oberg, K. [1 ]
Granberg, D. [1 ]
Lindholm, D. [1 ]
Eriksson, B. [1 ]
机构：
[1] Univ Uppsala Hosp, Dept Endocrine Oncol, Uppsala, Sweden
来源：
NEUROENDOCRINOLOGY | 2011年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [1] Response of the Primary Tumor in Patients with Pancreatic Neuroendocrine Tumors Treated with Streptozotocin/5-FU - A Preliminary Retrospective Study
    Reher, D.
    Henes, F. O.
    Gress, T. M.
    Lohse, A.
    Rinke, A.
    Schrader, J.
    NEUROENDOCRINOLOGY, 2019, 108 : 160 - 160
  • [2] 5-FU VERSUS COMBINATION THERAPY WITH TUBERCIDIN, STREPTOZOTOCIN, AND 5-FU IN THE TREATMENT OF PANCREATIC CARCINOMAS - COG PROTOCOL-7230
    AWRICH, A
    FLETCHER, WS
    KLOTZ, JH
    MINTON, JP
    HILL, GJ
    AUST, JB
    GRAGE, TB
    MULTHAUF, PM
    JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (03) : 267 - 273
  • [3] Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors
    Joerg Schrader
    Frank O. Henes
    Michael Blaeker
    Katharina Zimmermann-Fraedrich
    Andrea Pace
    Daniel Perez
    Jakob R. Izbicki
    Ansgar W. Lohse
    Daniel Benten
    Endocrine, 2019, 65 : 460 - 467
  • [4] Extended cycle streptozotocin/5-FU chemotherapy for maintenance therapy in pancreatic neuroendocrine tumors
    Schrader, Joerg
    Henes, Frank O.
    Blaeker, Michael
    Zimmermann-Fraedrich, Katharina
    Pace, Andrea
    Perez, Daniel
    Izbicki, Jakob R.
    Lohse, Ansgar W.
    Benten, Daniel
    ENDOCRINE, 2019, 65 (02) : 460 - 467
  • [5] Monitoring of the 5-FU therapy: Safety and efficacy of treatment?
    Szczesniak, Angelika
    Goryniak, Aleksandra
    Sleboda, Daria
    Dolegowska, Barbara
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2018, 72 : 81 - 88
  • [6] Streptozotocin in pancreatic neuroendocrine tumors: a focus on efficacy and safety
    La Salvia, Anna
    Bellino, Stefania
    Fanciulli, Giuseppe
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (02) : 115 - 118
  • [7] Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine Tumours
    Reher, Dominik
    Fehrenbach, Uli
    Kayser, Antonin
    Pape, Ulrich-Frank
    Henes, Frank Oliver
    Cremer, Birgit
    Hoersch, Dieter
    Izbicki, Jakob
    Lohse, Ansgar Wilhelm
    Rinke, Anja
    Schrader, Joerg
    NEUROENDOCRINOLOGY, 2022, 112 (06) : 595 - 605
  • [8] The efficacy and safety of combination chemotherapy with paclitaxel, 5-fluorouracil (5-FU) and cisplatin for advanced gastric carcinoma: A phase II study
    Kim, S.
    Lim, H.
    Lee, H.
    Yuh, Y.
    ANNALS OF ONCOLOGY, 2007, 18 : VII54 - VII55
  • [9] COMBINATION CHEMOTHERAPY WITH 5-FLUOROURACIL (5-FU), ADRIAMYCIN (AD), MITOMYCIN-C (MITO C), AND STREPTOZOTOCIN (STZ) OF PANCREATIC ADENOCARCINOMA
    SCHACTER, L
    BUKOWSKI, RM
    HEWLETT, JS
    GROPPE, C
    WEICK, J
    REIMER, R
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 420 - 420
  • [10] Synergistic effect of TTF and 5-FU combination treatment on pancreatic cancer cells
    Jo, Yunhui
    Lee, Eunjun
    Oh, Geon
    Gi, Yongha
    Yoon, Myonggeun
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (10): : 4734 - 4741
12345